Lawsuit Overview
<p>On Monday, April 28th, Taro Pharmaceuticals Ltd. announced, the same day a federal judge in the U.S. District Court for the Southern District of New York refused the company’s motion to dismiss the purported shareholder class action, that it had reached a settlement over a class action with the shareholders, who alleged the company that is sold excessive amounts of drugs in o...
You must register (for free) or login to view the entire case.